Get the Stockscreener App
2.62
9.34%
-0.27
Pre-market:
2.53
-0.09
-3.44%
Hcw Biologics Inc stock is traded at $2.62, with a volume of 2.92M.
It is down -9.34% in the last 24 hours and up +597.55% over the past month.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
See More
Previous Close:
$2.89
Open:
$2.72
24h Volume:
2.92M
Relative Volume:
0.16
Market Cap:
$17.64M
Revenue:
$54,200
Net Income/Loss:
$-22.30M
P/E Ratio:
-0.2222
EPS:
-11.793
Net Cash Flow:
$-13.39M
1W Performance:
+147.17%
1M Performance:
+597.55%
6M Performance:
+34.36%
1Y Performance:
-68.70%
1-Day Range:
$2.48
$2.97
1-Week Range:
$1.03
$3.99
52-Week Range:
$0.25
$8.7463
Hcw Biologics Inc Stock (HCWB) Company Profile
Name
Hcw Biologics Inc
Sector
Industry
Phone
954-842-2024
Address
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
2.62 | 19.46M | 54,200 | -22.30M | -13.39M | -11.79 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Hcw Biologics Inc Stock (HCWB) Latest News
HCW Biologics raises $4 million in private placement - Investing.com UK
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement - Investing News Network
HCW Biologics raises $4 million in private placement By Investing.com - Investing.com South Africa
HCWB Stock Explodes As Earnings Swing Fuels Biotech Rally - StocksToTrade
Why Is HCW Biologics Stock Surging On Friday? - Benzinga
HCW Biologics Announces $4 Million Private Placement Offering to Advance Clinical Pipeline and Debt Repayment - Minichart
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
HCWB SEC FilingsHcw Biologics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
HCW Biologics Raises $4 Million in Unit Offering, Adds Registration and Placement Agreements - TradingView
HCW Biologics (NASDAQ: HCWB) prices $4M private unit financing with warrants - Stock Titan
Why HCW Biologics Stock Is Surging On Thursday? - Benzinga
HCWB Stock Soars As Q1 Profit And Pipeline Fuel Momentum - StocksToTrade
HCW Biologics announces pricing of $4M private placement - TipRanks
HCW Biologics prices private placement of 2.8 mln units at $1.405 per unit - marketscreener.com
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules - The Manila Times
HCW Biologics Inc. Announces Pricing of Private Placement of 2,846,975 Units at $1.405 Each - Quiver Quantitative
HCW Biologics Inc. Announces Pricing of Approximately $4.0 - GlobeNewswire
Press Release: HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules - Moomoo
HCW Biologics Stock Surges 129% Amid Concerns - Intellectia AI
SLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX - RTTNews
HCW Biologics Jumps, Doubles Again as Traders Pile Into Biotech Name - TechStock²
Trending Stocks Today | HCW Biologics Surges 138.69% Pre-Market - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Trending Stocks Today | HCW Biologics Shoots up 151.88% - Moomoo
c'mon let hit 4. - Moomoo
$HCW Biologics (HCWB.US)$ 🫡 - Moomoo
Why Is Penny Stock HCW Biologics (HCWB) Up Today? - TipRanks
Why HCW Biologics Stock Is Falling On Tuesday? - Benzinga
HCW Biologics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingmoomoo - Moomoo
Trending Stocks Today | HCW Biologics Surges 278.33% - 富途牛牛
symbol__ Stock Quote Price and Forecast - CNN
These stocks have an unusual volume in today's session - ChartMill
$HCW Biologics (HCWB.US)$ thanks market!😎 - Moomoo
HCWB Stock Jumps After Licensing Deal But Faces Delisting Risk - timothysykes.com
HCW Biologics (NASDAQ: HCWB) extends $5.6M offering to May 22, 2026 - Stock Titan
HCW Biologics (HCWB) Stock Today: Rallies +9.84%, Resistance at $1.41 2026-05-18Theta Decay - newser.com
What's Going On With HCW Biologics Stock Monday? - Benzinga
HCW Biologics Soars After Earnings Shock And Pipeline Progress - timothysykes.com
Why Is HCW Biologics Stock Gaining Today? - Dailyhunt
HCW Biologics (HCWB) Stock: Big Revenue Quarter Can’t Mask Nasdaq Delisting Threat - MEXC
Volatile ride for HCW Biologics Inc. stock price on Friday moving between $0.99 and $1.42 - StockInvest.us
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update - TechStock²
Tech and AI Stocks Retreat, HCW Biologics Skyrockets - Let's Data Science
HCW Biologics (HCWB) Posted a Rare Profit, but the Financing Question Is Still Open - AlphaStreet
Clinical-Stage Biopharma Surges on Profit Swing and Imminent Phase 1 Data Readout - The Globe and Mail
Armistice Capital and Steven Boyd report 4.99% stake in HCWB (HCWB) - Stock Titan
HCW Biologics (HCWB) Stock: Licensing Deal Fuels Q1 Revenue Surge Amid Nasdaq Compliance Battle - MEXC
HCW Biologics Jumps 309% as Traders React to Licensing-driven Q1 Profit and Revenue Surge - Moomoo
HCW Biologics jumps 309% as traders react to licensing-driven Q1 profit and revenue surge - Quiver Quantitative
$HCW Biologics (HCWB.US)$ 😘 - Moomoo
HCW Biologics Inc.'s (NASDAQ: HCWB) Big Gains on Q1 RevenueSurges 493% to $6.53M - Investorideas.com
Hcw Biologics Inc Stock (HCWB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):